Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Platelet activation is a critical physiological process in hemostasis, the mechanism that stops bleeding and initiates tissue repair following vascular injury. It involves the transformation of platelets from a resting state to an active state, enabling them to adhere to sites of vessel damage, aggregate with other platelets, and interact with coagulation factors to form a stable blood clot. Dysregulated platelet activation contributes to various disorders including arterial thrombosis, myocardial infarction, and stroke. Excessive or insufficient platelet activity can lead respectively to unwanted clot formation or bleeding diatheses.
Various mechanisms including inhibition of cyclooxygenase (COX), ADP receptor antagonism, and GPIIb/IIIa receptor antagonism
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Platelet Activation.